1. Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes. Issue 13 (1st May 2021) Authors: Garcia-Manero, Guillermo; Santini, Valeria; Almeida, Antonio; Platzbecker, Uwe; Jonasova, Anna; Silverman, Lewis R.; Falantes, Jose; Reda, Gianluigi; Buccisano, Francesco; Fenaux, Pierre; Buckstein, Rena; Diez Campelo, Maria; Larsen, Stephen; Valcarcel, David; Vyas, Paresh; Giai, Valentina; Olíva... Journal: Journal of clinical oncology Issue: Volume 39:Issue 13(2021) Page Start: 1426 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗